The company will launch the vaccine against RSV in the United States in the autumn
July 31, 2023: On Wednesday, GlaxoSmithKline CEO Emma Walmsley said she hopes slow takes for the group’s RSV vaccine to start slower …
July 31, 2023: On Wednesday, GlaxoSmithKline CEO Emma Walmsley said she hopes slow takes for the group’s RSV vaccine to start slower …